Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety Evaluation for 24 Weeks Intake of Korean Red Ginseng in Adults: A Randomized, Double-blind, Placebo-controlled, Parallel, Multi-center, Exploratory Trial

NCT02428998 is registered in ClinicalTrials.gov with Korea Ginseng Corporation as lead sponsor.

NCT NCT02428998
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02428998 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety Evaluation for 24 Weeks Intake of Korean Red Ginseng in Adults: A Randomized, Double-blind, Placebo-controlled, Parallel, Multi-center, Exploratory Trial
Lead sponsor
Korea Ginseng Corporation
Phase
Not applicable
Overall status
Completed
Start date
September 30, 2014
Completion date
April 30, 2017
Enrollment
1,000 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes, healthy, hyperlipidemia, hypertension